CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
+9.45%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$98.4B
AUM Growth
+$5.17B
(+5.5%)
Cap. Flow
-$1.86B
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
19.82%
Holding
3,993
New
37
Increased
2,065
Reduced
935
Closed
663
Top Buys
| 1 |
Enlight Renewable Energy
ENLT
|
+$1.29B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$290M |
| 3 |
Microsoft
MSFT
|
+$157M |
| 4 |
UBS Group
UBS
|
+$134M |
| 5 |
Mercado Libre
MELI
|
+$112M |
Top Sells
| 1 |
Amazon
AMZN
|
+$330M |
| 2 |
NVIDIA
NVDA
|
+$270M |
| 3 |
Apple
AAPL
|
+$253M |
| 4 |
Alibaba
BABA
|
+$230M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$226M |
Sector Composition
| 1 | Technology | 24.04% |
| 2 | Healthcare | 15.7% |
| 3 | Financials | 13.65% |
| 4 | Consumer Discretionary | 9.37% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Cellebrite
CLBT
$4.24B
| $182K | ﹤0.01% |
29,948
-11,581
| -28% | -$70.5K |
|
3002
Vuzix
VUZI
$180M
| $181K | ﹤0.01% |
43,750
+16
| +0% | +$66 |
|
3003
Prime Medicine
PRME
$729M
| $181K | ﹤0.01% |
14,705
+13,905
| +1,738% | +$171K |
|
3004
Entrada Therapeutics
TRDA
$202M
| $180K | ﹤0.01% |
12,399
+3,588
| +41% | +$52K |
|
3005
Organogenesis Holdings
ORGO
$636M
| $179K | ﹤0.01% |
84,248
+15
| +0% | +$32 |
|
3006
AerSale
ASLE
$395M
| $179K | ﹤0.01% |
10,377
+4
| +0% | +$69 |
|
|
TDCX
3007
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $179K | ﹤0.01% |
20,061
-66
| -0.3% | -$587 |
|
|
OTLY
3008
Oatly Group
OTLY
$520M
| $177K | ﹤0.01% |
3,653
-2,621
| -42% | -$127K |
|
3009
HUTCHMED
HCM
$2.81B
| $176K | ﹤0.01% |
13,548
| – | – |
|
3010
Clarus
CLAR
$151M
| $175K | ﹤0.01% |
18,497
+6
| +0% | +$57 |
|
3011
Altimmune
ALT
$329M
| $175K | ﹤0.01% |
41,372
+3,235
| +8% | +$13.7K |
|
|
LEV
3012
DELISTED
The Lion Electric Company
LEV
| $172K | ﹤0.01% |
92,314
-295
| -0.3% | -$549 |
|
3013
Butterfly Network
BFLY
$378M
| $170K | ﹤0.01% |
90,581
+14,539
| +19% | +$27.3K |
|
3014
Alkami Technology
ALKT
$2.6B
| $170K | ﹤0.01% |
13,442
+998
| +8% | +$12.6K |
|
3015
Hyliion Holdings
HYLN
$291M
| $167K | ﹤0.01% |
84,594
+30
| +0% | +$59 |
|
|
KLRS
3016
Kalaris Therapeutics, Inc. Common Stock
KLRS
$84.3M
| $165K | ﹤0.01% |
1,825
+208
| +13% | +$18.8K |
|
3017
Douglas Elliman
DOUG
$237M
| $164K | ﹤0.01% |
55,231
+20
| +0% | +$59 |
|
3018
CarParts.com
PRTS
$47.5M
| $162K | ﹤0.01% |
30,401
+6,278
| +26% | +$33.5K |
|
3019
Kodiak Sciences
KOD
$523M
| $161K | ﹤0.01% |
26,030
+9
| +0% | +$56 |
|
3020
Soho House & Co
SHCO
$1.73B
| $159K | ﹤0.01% |
24,330
+8
| +0% | +$52 |
|
3021
Dream Finders Homes
DFH
$2.8B
| $158K | ﹤0.01% |
11,923
+5
| +0% | +$66 |
|
|
RAIN
3022
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $157K | ﹤0.01% |
18,000
| – | – |
|
|
CTEV
3023
Claritev Corporation
CTEV
$1.04B
| $156K | ﹤0.01% |
3,673
+1
| +0% | +$42 |
|
|
IGMS
3024
DELISTED
IGM Biosciences
IGMS
| $154K | ﹤0.01% |
11,211
+2,823
| +34% | +$38.8K |
|
3025
Lexicon Pharmaceuticals
LXRX
$411M
| $154K | ﹤0.01% |
63,385
+20
| +0% | +$49 |
|